Can AI Predict Preterm Birth in Diabetic, Hypertensive Pregnancies? - Top-Institutions - MDSpire

Can AI Predict Preterm Birth in Diabetic, Hypertensive Pregnancies?

Retrospective study finds machine-learning model identifies clinical factors associated with preterm delivery in a high-risk obstetric population.

  • By

  • Julia Cipriano, MS, CMPP

  • February 24, 2026

  • 3 min

Share

Top Institutions in Endocrinology

Brief introduction explaining scope and methodology.

  • #1

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Maternal-Fetal Medicine
    • Obstetrics
    • Clinical Informatics
    • Machine Learning in Healthcare

  • #2

    Stanford University Medical Center
    Stanford University Medical Center

    Stanford, CA

    Key Differentiators

    • Maternal-Fetal Medicine
    • Biomedical Informatics
    • Machine Learning

  • #3

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Maternal-Fetal Medicine
    • Perinatal Epidemiology
    • Clinical Data Science

  • #4

    Johns Hopkins Hospital
    Johns Hopkins Hospital

    Baltimore, MD

    Key Differentiators

    • Obstetrics and Gynecology
    • Biomedical Engineering
    • Health Informatics

  • #5

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Maternal-Fetal Medicine
    • Clinical Informatics
    • AI in Healthcare

Original Source(s)

Can AI Predict Preterm Birth in Diabetic, Hypertensive Pregnancies?

  • by Julia Cipriano, MS, CMPP

  • February 24, 2026

Related Content

Editorial: Cardiovascular Anthropometry For Large Scale Population Studies Volume II

Predictors of early response to GnRH and gonadotropin therapy in pediatric patients with suspected dual congenital hypogonadotropic hypogonadism: a retrospective single-center study

Opposing gastric and jejunal regulation of CELA2A in obesity and after Roux-en-Y gastric bypass suggests a role in gastrointestinal metabolic signaling